Sanctuary Advisors LLC Takes $222,000 Position in Azenta, Inc. (NASDAQ:AZTA)

Sanctuary Advisors LLC acquired a new position in Azenta, Inc. (NASDAQ:AZTAFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,253 shares of the company’s stock, valued at approximately $222,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Hantz Financial Services Inc. acquired a new stake in Azenta during the 2nd quarter valued at approximately $30,000. Benjamin F. Edwards & Company Inc. bought a new position in Azenta during the first quarter worth $38,000. BI Asset Management Fondsmaeglerselskab A S bought a new position in Azenta during the first quarter worth $49,000. Lazard Asset Management LLC acquired a new position in Azenta in the first quarter valued at $130,000. Finally, Acadian Asset Management LLC boosted its position in Azenta by 24.7% during the first quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock valued at $143,000 after acquiring an additional 471 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Trading Up 1.4 %

NASDAQ:AZTA opened at $44.14 on Monday. Azenta, Inc. has a 12 month low of $43.42 and a 12 month high of $69.16. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of -16.29 and a beta of 1.47. The firm has a fifty day simple moving average of $48.10 and a two-hundred day simple moving average of $51.93.

Azenta (NASDAQ:AZTAGet Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.16 EPS for the quarter, beating the consensus estimate of $0.07 by $0.09. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The company had revenue of $173.00 million during the quarter, compared to the consensus estimate of $166.14 million. During the same period last year, the business posted $0.13 EPS. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. Equities analysts predict that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on AZTA shares. Needham & Company LLC reissued a “buy” rating and issued a $69.00 price objective on shares of Azenta in a research report on Wednesday, August 7th. Evercore ISI decreased their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Azenta currently has an average rating of “Hold” and a consensus price target of $66.40.

View Our Latest Analysis on Azenta

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Recommended Stories

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.